- CrossSense AI smart glasses gain recognition as funding flows into dementia support tools
- $1.4 million prize reflects growing reliance on technology in cognitive care strategies
- Early results suggest benefits, but long-term clinical effectiveness is yet to be confirmed
The Longitude Prize on Dementia has awarded £1 million (roughly $1.4 million) to a smart-glasses system designed to support people living with dementia.
Backed by Alzheimer’s Society and Innovate UK, the prize is a major incentive for practical innovation rather than theoretical research.
The winning system, CrossSense, introduces an AI assistant embedded in smart glasses that observes surroundings and delivers prompts during everyday activities.
Smart glasses and an adaptive AI assistant
The assistant, named Wispy, learns user habits over time and adjusts its guidance as cognitive decline progresses.
According to its developers, the assistant supports routine tasks such as preparing food, managing household chores, and navigating social interactions — it “sees what you see, hears what you hear, and can speak with you.”
The aim is to enhance the user's experience and reduce confusion while preserving autonomy, although this relies heavily on consistent user engagement and accurate interpretation of context.
“Winning the Longitude Prize on Dementia is a dream come true. As a small team with big ambitions, the prize’s support has accelerated CrossSense in ways that wouldn’t have been possible otherwise,” said Szczepan Orlins, CEO, CrossSense Ltd.
“The technology is designed to support daily living, integrating multiple senses to simplify essential tasks… This win brings us closer to making CrossSense available to the public within the next year.”
Early observations conducted with the University of Sussex suggest some improvements in object recognition, memory use, and spatial awareness among users.
The system also attempts to reinforce cognitive links between objects and actions, which developers argue may slow the decline in early-stage dementia.
However, these findings remain limited in scope and are not yet supported by large-scale longitudinal studies.
“CrossSense captures exactly the kind of revolutionary AI the Longitude Prize set out to support,” said Dame Wendy Hall, internationally renowned AI expert and chair of the Longitude Committee.
“The team’s progress over the past three years has been remarkable… The prize has helped accelerate multiple solutions that will soon be available.”
Dementia continues to expand globally, with no cure currently available, emphasizing supportive technologies rather than treatment.
CrossSense aligns with this shift, focusing on day-to-day functionality rather than medical intervention.
“Rapid advancements in AI will give people affected by early-stage dementia the opportunity to stay safely in their own homes for longer and lead more independent, fulfilled lives,” said Professor Fiona Carragher, Chief Policy and Research Officer at Alzheimer’s Society.
“The CrossSense smart glasses companion is a prime example of harnessing technology to develop intuitive personal support that complements care given by humans.”
The UK government is proud of CrossSense’s work, acknowledging dementia as a “dreadful condition which affects millions of people and their loved ones in all parts of the UK.”
“CrossSense’s work will help people living with dementia lead more independent lives in confidence. Its work is a brilliant example of how British-led research can deliver real and life-transforming benefits,” said Lord Vallance, the UK Science Minister.
While the recognition and funding signal confidence in AI-assisted care, questions remain about long-term adoption, data privacy, and measurable outcomes beyond controlled settings.
